BioCryst Pharmaceuticals BCRX Payments to Acquire Businesses, Net of Cash Acquired
Payments to Acquire Businesses, Net of Cash Acquired at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's payments to acquire businesses, net of cash acquired.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's payments to acquire businesses, net of cash acquired?
- BioCryst Pharmaceuticals (BCRX) reported payments to acquire businesses, net of cash acquired of $489.48M in Q1 2026.